Skip to content
healthcare.dev
Get a free key

Belmora Flanax

NDC 27854-555, Naproxen Sodium, tablet, from Belmora LLC.

Product NDC
27854-555
Status
Listed
Labeler
Belmora LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA090545
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/27854-555 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NAPROXEN SODIUM220 mg/1

Pharmacologic classes

Anti-Inflammatory Agents, Non-Steroidal [CS]; Cyclooxygenase Inhibitors [MoA]; Nonsteroidal Anti-inflammatory Drug [EPC]

Package NDCNDC-11Package
27854-555-01278540555011 BOTTLE in 1 CARTON (27854-555-01) / 24 TABLET in 1 BOTTLE
27854-555-022785405550240 PACKET in 1 BOX (27854-555-02) / 1 TABLET in 1 PACKET

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 27854-555 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/27854-555 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 27854-555. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.